Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

DiaSorin S.p.A. (DSRLF) Stock Price & Analysis

1 Followers

DSRLF Stock Chart & Stats

$92.53$2.59(2.89%)
At close: 4:00 PM EST
$80$85$90Aug 7Aug 19Oct 2Oct 16Oct 26
Day’s Range
$87.84 - $97.21
52-Week Range
$63.71 - $97.21
Previous Close
$89.93
Volume
N/A
Average Volume (3M)
11
Market Cap
$4.88B
Enterprise Value
$4.22B
Total Cash (Recent Filing)
$120.88M
Total Debt (Recent Filing)
$959.49M
Price to Earnings (P/E)
25.6
Beta
0.71
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
1.02
Last Dividend Ex-Date
May 19, 2026
Dividend Yield
1.75%

Bulls Say, Bears Say

Bulls Say

Recurring Consumables Revenue

DiaSorin's business model earns a large portion of revenue from repeat purchases of reagents and assay kits used on installed instruments. This creates high revenue visibility and stickiness: once instruments are placed, ongoing utilization drives predictable, utilization-linked consumable demand over multiple years.

Strong Cash Generation

Consistent operating cash flow and high free cash flow conversion support durable financial flexibility. Strong FCF funds R&D, instrument placements, service expansion, and reduces reliance on external financing, enabling strategic reinvestment and shareholder returns over the medium term.

Improved Balance Sheet

Meaningfully reduced leverage lowers financial risk and increases strategic optionality. A stronger equity base and lower debt burden improve resilience through testing-demand cycles, support potential M&A or capital investments, and decrease vulnerability to interest-rate shocks over the medium term.

Bears Say

Below-Peak Profitability

Net margin and ROE remain below the company's earlier cycle peaks, indicating profitability has not fully recovered. Sustained lower margins constrain retained earnings and returns to shareholders, and may reflect structural price/mix pressure or higher operating costs that could persist absent operational improvements.

Historical Cash-Flow Volatility

Revenue and free cash flow have swung materially across recent years. This cyclical and volatile cash profile complicates long-term planning for capex and R&D, raises forecasting risk, and means returns and distributions could be uneven across 2–6 month horizons if testing demand or reimbursement dynamics shift.

Dependence On Testing Volumes & Installed Base

A significant portion of revenue depends on instrument placements and subsequent test utilization. Slower instrument adoption, competitive wins by rivals, or secular declines in test volumes (e.g., fewer infectious disease tests) would directly reduce consumable sales and service revenue, pressuring growth durability.

DiaSorin S.p.A. News

DSRLF FAQ

What was DiaSorin S.p.A.’s price range in the past 12 months?
DiaSorin S.p.A. lowest stock price was $63.71 and its highest was $97.21 in the past 12 months.
What is DiaSorin S.p.A.’s market cap?
DiaSorin S.p.A.’s market cap is $4.88B.
When is DiaSorin S.p.A.’s upcoming earnings report date?
DiaSorin S.p.A.’s next earnings report is estimated for Nov 12, 2026 (not yet confirmed), which is in 6 days.
How were DiaSorin S.p.A.’s earnings last quarter?
DiaSorin S.p.A. released its earnings results on Jul 31, 2026. The company reported $1.227 earnings per share for the quarter, beating the consensus estimate of $1.104 by $0.123.
Is DiaSorin S.p.A. overvalued?
According to Wall Street analysts DiaSorin S.p.A.’s price is currently Overvalued.
Does DiaSorin S.p.A. pay dividends?
DiaSorin S.p.A. pays a Annually dividend of $1.508 which represents an annual dividend yield of 1.75%. See more information on DiaSorin S.p.A. dividends here
What is DiaSorin S.p.A.’s EPS estimate?
DiaSorin S.p.A.’s EPS estimate is 1.02.
How many shares outstanding does DiaSorin S.p.A. have?
DiaSorin S.p.A. has 55,948,257 shares outstanding.
What happened to DiaSorin S.p.A.’s price movement after its last earnings report?
DiaSorin S.p.A. reported an EPS of $1.227 in its last earnings report, beating expectations of $1.104. Following the earnings report the stock price went up 4.054%.
Which hedge fund is a major shareholder of DiaSorin S.p.A.?
Currently, no hedge funds are holding shares in DSRLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology